ROSSARI:NSE-Rossari Biotech Limited (INR)

COMMON STOCK | Specialty Chemicals | NSE

Last Closing Price

INR 967.75

Change

+30.00 (+3.20)%

Market Cap

INR 51.81B

Volume

0.03M

Avg Analyst Target

INR 1,076.40 (+11.23%)

Avg User Target

INR
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


ROSSARI Stock Forecast & Price:
Based on the Rossari Biotech Limited stock forecasts from 3 analysts, the average analyst target price for Rossari Biotech Limited is INR 1,076.40 over the next 12 months. Rossari Biotech Limited’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Rossari Biotech Limited is Slightly Bearish, which is based on 4 positive signals and 8 negative signals. At the last closing, Rossari Biotech Limited’s stock price was INR 967.75. Rossari Biotech Limited’s stock price has changed by -0.67% over the past week, +2.54% over the past month and -33.26% over the last year.

About Rossari Biotech Limited (ROSSARI:NSE)

Rossari Biotech Limited engages in manufacture and sale of specialty chemicals in India and internationally. It offers soap and detergents; inks, paints, and coatings; ceramics and tiles; pulp and papers; cement; and water treatment solutions. The company also provides textile sp ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-09-27 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ASIANPAINT:NSE Asian Paints Limited

+32.60 (+0.95%)

INR3,313.38B 95.28 57.01
PIDILITIND:NSE Pidilite Industries Limited

+2.10 (+0.07%)

INR1,430.61B 106.73 68.29
SRF:NSE SRF Limited

-26.35 (-1.05%)

INR754.52B 35.08 22.57
BERGEPAINT:NSE Berger Paints (I) Limited

+1.75 (+0.28%)

INR611.51B 64.68 39.71
SOLARINDS:NSE Solar Industries India Limited

+153.55 (+4.46%)

INR345.03B 62.50 36.18
AARTIIND:NSE Aarti Industries Limited

-8.00 (-0.98%)

INR293.03B 22.02 16.87
LINDEINDIA:NSE Linde India Limited

-83.30 (-2.57%)

INR289.12B 74.37 47.84
ATUL:NSE Atul Limited

-25.60 (-0.29%)

INR265.81B 44.18 26.92
KANSAINER:NSE Kansai Nerolac Paints Limited

+11.75 (+2.48%)

INR255.15B 63.70 35.18
FINEORG:NSE Fine Organic Industries Limite..

+77.05 (+1.10%)

INR219.61B 56.64 37.89

ETFs Containing ROSSARI

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Specialty Chemicals)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -24.60% 18% F 23% F
Dividend Return 0.04% 2% F 1% F
Total Return -24.56% 18% F 22% F
Trailing 12 Months  
Capital Gain -33.31% 12% F 10% F
Dividend Return 0.03% 2% F 1% F
Total Return -33.28% 12% F 9% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 11.12% 39% F 40% F
Dividend Return 0.00% 1% F 1% F
Total Return 11.12% 36% F 38% F
Risk Return Profile  
Volatility (Standard Deviation) 36.23% 76% C 76% C
Risk Adjusted Return 30.68% 45% F 48% F
Market Capitalization 51.81B 75% C 74% C
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Specialty Chemicals)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 51.65 25% F 20% F
Price/Book Ratio 6.42 29% F 18% F
Price / Cash Flow Ratio 176.49 11% F 4% F
EV/EBITDA 23.69 35% F 22% F
Management Effectiveness  
Return on Equity 16.10% 50% F 65% D
Return on Invested Capital 15.84% 60% D- 78% C+
Return on Assets 8.89% 59% F 79% C+
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Dividend Yield 0.05% 1% F 1% F
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.69 56% F 63% D
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (INR)

Quarterly Financials (INR)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Discussions

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.